Literature DB >> 23432468

Defective thymic progenitor development and mature T-cell responses in a mouse model for Down syndrome.

Laureanne P E Lorenzo1, Kristen E Shatynski, Sarah Clark, Paul J Yarowsky, Mark S Williams.   

Abstract

In addition to archetypal cognitive defects, Down syndrome (DS) is characterized by altered lymphocyte development and function, including premature thymic involution and increased incidence of infections. However, the potential mechanisms for these changes have not been fully elucidated. The current study used the Ts65Dn mouse model of DS to assess deficiencies in T-cell development and possible molecular alterations. Ts65Dn mice exhibited premature thymic involution and a threefold to fourfold decrease in the number and proportion of immature, double-negative thymocyte progenitors. In addition, there were twofold fewer double-positive and CD4 single-positive thymocytes in Ts65Dn thymuses. Reflecting this deficient thymic function, there were fewer naive T cells in the spleen and polyclonal stimulation of peripheral T cells exhibited a marked reduction in proliferation, suggesting a senescent phenotype. In contrast, B-cell progenitors were unchanged in the bone marrow of Ts65Dn mice, but in the spleen, there were decreased transitional and follicular B cells and these cells proliferated less upon antigen receptor stimulus but not in response to lipopolysaccharide. As a potential mechanism for diminished thymic function, immature thymocyte populations expressed diminished levels of the cytokine receptor interleukin-7Rα, which was associated with decreased proliferation and increased apoptosis. Increased oxidative stress and inhibition of the Notch pathway were identified as possible mediators of decreased interleukin-7Rα expression in Ts65Dn mice. The data suggest that immature thymocyte defects underlie immune dysfunction in DS and that increased oxidative stress and reduced cytokine signalling may alter lymphocyte development in Ts65Dn mice.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  Down syndrome; interleukin-7 receptor; lymphocyte development; reactive oxygen species; thymus

Mesh:

Substances:

Year:  2013        PMID: 23432468      PMCID: PMC3719062          DOI: 10.1111/imm.12092

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  53 in total

1.  Attenuation of Notch signalling by the Down-syndrome-associated kinase DYRK1A.

Authors:  Javier Fernandez-Martinez; Eva M Vela; Mireille Tora-Ponsioen; Oscar H Ocaña; M Angela Nieto; Juan Galceran
Journal:  J Cell Sci       Date:  2009-04-21       Impact factor: 5.285

Review 2.  MicroRNAs: new regulators of immune cell development and function.

Authors:  David Baltimore; Mark P Boldin; Ryan M O'Connell; Dinesh S Rao; Konstantin D Taganov
Journal:  Nat Immunol       Date:  2008-08       Impact factor: 25.606

3.  Down syndrome B-lymphocyte subpopulations, intrinsic defect or decreased T-lymphocyte help.

Authors:  Ruud H J Verstegen; Maaike A A Kusters; Eugenie F A Gemen; Esther DE Vries
Journal:  Pediatr Res       Date:  2010-05       Impact factor: 3.756

Review 4.  Naive T cell homeostasis: from awareness of space to a sense of place.

Authors:  Kensuke Takada; Stephen C Jameson
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

5.  Regulation of notch1 signaling by nrf2: implications for tissue regeneration.

Authors:  Nobunao Wakabayashi; Soona Shin; Stephen L Slocum; Elin S Agoston; Junko Wakabayashi; Mi-Kyoung Kwak; Vikas Misra; Shyam Biswal; Masayuki Yamamoto; Thomas W Kensler
Journal:  Sci Signal       Date:  2010-07-13       Impact factor: 8.192

6.  Decreased thymic output accounts for decreased naive T cell numbers in children with Down syndrome.

Authors:  Beatrijs L P Bloemers; Louis Bont; Roel A de Weger; Sigrid A Otto; Jose A Borghans; Kiki Tesselaar
Journal:  J Immunol       Date:  2011-02-23       Impact factor: 5.422

7.  Homeostatic cytokines and expansion of regulatory T cells accompany thymic impairment in children with Down syndrome.

Authors:  Erika Roat; Nicole Prada; Enrico Lugli; Milena Nasi; Roberta Ferraresi; Leonarda Troiano; Chiara Giovenzana; Marcello Pinti; Ornella Biagioni; Mauro Mariotti; Angelo Di Iorio; Ugo Consolo; Fiorella Balli; Andrea Cossarizza
Journal:  Rejuvenation Res       Date:  2008-06       Impact factor: 4.663

8.  Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human Down syndrome brains.

Authors:  Donald E Kuhn; Gerard J Nuovo; Alvin V Terry; Mickey M Martin; Geraldine E Malana; Sarah E Sansom; Adam P Pleister; Wayne D Beck; Elizabeth Head; David S Feldman; Terry S Elton
Journal:  J Biol Chem       Date:  2009-11-06       Impact factor: 5.157

Review 9.  Intrinsic defect of the immune system in children with Down syndrome: a review.

Authors:  M A A Kusters; R H J Verstegen; E F A Gemen; E de Vries
Journal:  Clin Exp Immunol       Date:  2009-01-22       Impact factor: 4.330

10.  CSL-MAML-dependent Notch1 signaling controls T lineage-specific IL-7R{alpha} gene expression in early human thymopoiesis and leukemia.

Authors:  Sara González-García; Marina García-Peydró; Enrique Martín-Gayo; Esteban Ballestar; Manel Esteller; Rafael Bornstein; José Luis de la Pompa; Adolfo A Ferrando; María L Toribio
Journal:  J Exp Med       Date:  2009-04-06       Impact factor: 14.307

View more
  9 in total

Review 1.  Rodent Modeling of Alzheimer's Disease in Down Syndrome: In vivo and ex vivo Approaches.

Authors:  Clíona Farrell; Paige Mumford; Frances K Wiseman
Journal:  Front Neurosci       Date:  2022-06-07       Impact factor: 5.152

2.  Pericentrin expression in Down's syndrome.

Authors:  Michele Salemi; Concetta Barone; Carmelo Romano; Roberto Salluzzo; Filippo Caraci; Rita Anna Cantarella; Maria Grazia Salluzzo; Filippo Drago; Corrado Romano; Paolo Bosco
Journal:  Neurol Sci       Date:  2013-08-27       Impact factor: 3.307

3.  Gadolinium chloride suppresses acute rejection and induces tolerance following rat liver transplantation by inhibiting Kupffer-cell activation.

Authors:  Yakun Wu; Yunbing Wang; Min Li; Xiaoli Yang; Jianping Gong; Wei Zhang
Journal:  Exp Ther Med       Date:  2014-10-10       Impact factor: 2.447

4.  Oxidant production and SOD1 protein expression in single skeletal myofibers from Down syndrome mice.

Authors:  Patrick M Cowley; Divya R Nair; Lara R DeRuisseau; Stefan Keslacy; Mustafa Atalay; Keith C DeRuisseau
Journal:  Redox Biol       Date:  2017-07-04       Impact factor: 11.799

5.  Thymic Epithelium Abnormalities in DiGeorge and Down Syndrome Patients Contribute to Dysregulation in T Cell Development.

Authors:  Genni Enza Marcovecchio; Ileana Bortolomai; Francesca Ferrua; Elena Fontana; Luisa Imberti; Erika Conforti; Donato Amodio; Sonia Bergante; Giulia Macchiarulo; Veronica D'Oria; Francesca Conti; Silvia Di Cesare; Georgia Fousteri; Adriano Carotti; Alessandro Giamberti; Pietro Luigi Poliani; Luigi D Notarangelo; Caterina Cancrini; Anna Villa; Marita Bosticardo
Journal:  Front Immunol       Date:  2019-03-15       Impact factor: 7.561

Review 6.  Down syndrome, accelerated aging and immunosenescence.

Authors:  Noémie Gensous; Maria Giulia Bacalini; Claudio Franceschi; Paolo Garagnani
Journal:  Semin Immunopathol       Date:  2020-07-23       Impact factor: 9.623

7.  Premature Senescence and Increased Oxidative Stress in the Thymus of Down Syndrome Patients.

Authors:  Genni Enza Marcovecchio; Francesca Ferrua; Elena Fontana; Stefano Beretta; Marco Genua; Ileana Bortolomai; Anastasia Conti; Davide Montin; Maria Teresa Cascarano; Sonia Bergante; Veronica D'Oria; Alessandro Giamberti; Donato Amodio; Caterina Cancrini; Adriano Carotti; Raffaella Di Micco; Ivan Merelli; Marita Bosticardo; Anna Villa
Journal:  Front Immunol       Date:  2021-06-01       Impact factor: 7.561

8.  Modular transcriptional repertoire and MicroRNA target analyses characterize genomic dysregulation in the thymus of Down syndrome infants.

Authors:  Carlos Alberto Moreira-Filho; Silvia Yumi Bando; Fernanda Bernardi Bertonha; Filipi Nascimento Silva; Luciano da Fontoura Costa; Leandro Rodrigues Ferreira; Glaucio Furlanetto; Paulo Chacur; Maria Claudia Nogueira Zerbini; Magda Carneiro-Sampaio
Journal:  Oncotarget       Date:  2016-02-16

9.  Differential Expression of Inflammation-Related Genes in Children with Down Syndrome.

Authors:  Cláudia Regina Santos Silva; Joice Matos Biselli-Périco; Bruna Lancia Zampieri; Wilson Araujo Silva; Jorge Estefano Santana de Souza; Matheus Carvalho Bürger; Eny Maria Goloni-Bertollo; Érika Cristina Pavarino
Journal:  Mediators Inflamm       Date:  2016-05-11       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.